The essential role of pharmacists in antibiotic stewardship in outpatient care: An official position statement of the Society of Infectious Diseases Pharmacists

被引：42

作者：

Blanchette, Lisa ^{[1
]}

Gauthier, Timothy ^{[2
]}

Heil, Emily ^{[3
]}

Klepser, Michael ^{[4
]}

Kelly, Karl Madaras ^{[5
]}

Nailor, Michael ^{[6
]}

Wei, Wenjing ^{[7
]}

Suda, Katie ^{[8
]}

机构：

[1] Novant Hlth Presbyterian Med Ctr, Charlotte, NC USA

[2] Miami Vet Affairs Healthcare Syst, Miami, FL USA

[3] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA

[4] Ferris State Univ, Coll Pharm, Big Rapids, MI USA

[5] Idaho State Univ, Coll Pharm, Meridian, ID USA

[6] St Josephs Hosp, Phoenix, AZ USA

[7] Parkland Hosp, Austin, TX USA

[8] Univ Illinois, Coll Pharm, Chicago, IL USA

来源：

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION | 2018年 / 58卷 / 05期

关键词：

CLOSTRIDIUM-DIFFICILE INFECTION; EMERGENCY-DEPARTMENT VISITS; UNITED-STATES; ANTIMICROBIAL STEWARDSHIP; STREPTOCOCCAL PHARYNGITIS; RESISTANCE; PNEUMONIAE; SELECTION; SETTINGS; RATES;

D O I：

10.1016/j.japh.2018.05.013

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Objectives: The objective of this position statement is to describe the essential role of pharmacists in antimicrobial stewardship in outpatient care. Data sources: N/A. Summary: The majority of antibiotic prescribing occurs in outpatient care settings highlighting the need for antibiotic stewardship in the community. Given their expertise on medication management, pharmacists are essential to any antibiotic stewardship effort. Conclusion: As the regulations for antibiotic stewardship in outpatient settings continue to evolve and optimal stewardship strategies are defined, pharmacists must be leaders in the implementation of these programs. (C) 2018 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.

引用

页码：481 / 484

页数：4

共 50 条

[31] Building an Antimicrobial Stewardship Program: Cooperative Roles for Pharmacists, Infectious Diseases Specialists, and Clinical Microbiologists
Kim, Jihye
Craft, David W.
Katzman, Michael
LABMEDICINE, 2015, 46 (03): : E65 - E71
[32] Antibiotic cost containment with "on-call" infectious diseases pharmacists as a side effect to enhanced patient care.
Scheetz, MH
Postelnick, MJ
Scarsi, KK
Gerzenshtein, L
Fotis, MA
Bolon, MK
Noskin, GA
PHARMACOTHERAPY, 2005, 25 (03): : 480 - 480
[33] Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Rybak, Michael J.
Le, Jennifer
Lodise, Thomas P.
Levine, Donald P.
Bradley, John S.
Liu, Catherine
Mueller, Bruce A.
Pai, Manjunath P.
Wong-Beringer, Annie
Rotschafer, John C.
Rodvold, Keith A.
Maples, Holly D.
Lomaestro, Benjamin
CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) : 1361 - 1364
[34] Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Rybak, Michael J.
Le, Jennifer
Lodise, Thomas P.
Levine, Donald P.
Bradley, John S.
Liu, Catherine
Mueller, Bruce A.
Pai, Manjunath P.
Wong-Beringer, Annie
Rotschafer, John C.
Rodvold, Keith A.
Maples, Holly D.
Lomaestro, Benjamin M.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (11) : 835 - 863
[35] Advancing the role of pharmacists in infectious diseases: Fostering critical thinking and collaboration
May, Stephanie S.
Chastain, Daniel B.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024,
[36] Pharmacists' role in antimicrobial stewardship and relationship with antibiotic consumption in hospitals: An observational multicentre study
Ourghanlian, Clement
Lapidus, Nathanael
Antignac, Marie
Fernandez, Christine
Dumartin, Catherine
Hindlet, Patrick
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 : 131 - 134
[37] Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists (vol 49, pg 325, 2009)
Rybak, M. J.
Lomaestro, B. M.
Rotscahfer, J. C.
CLINICAL INFECTIOUS DISEASES, 2009, 49 (09) : 1465 - 1465
[38] Infectious Diseases Society of America Position Statement on Telehealth and Telemedicine as Applied to the Practice of Infectious Diseases
Young, Jeremy D.
Abdel-Massih, Rima
Herchline, Thomas
McCurdy, Lewis
Moyer, Kay J.
Scott, John D.
Wood, Brian R.
Siddiqui, Javeed
CLINICAL INFECTIOUS DISEASES, 2019, 68 (09) : 1437 - 1443
[39] Infectious Diseases Society of America Position Statement on Telehealth and Telemedicine as Applied to the Practice of Infectious Diseases
Siddiqui, Javeed
Herchline, Thomas
Kahlon, Summerpal
Moyer, Kay J.
Scott, John D.
Wood, Brian R.
Young, Jeremy
CLINICAL INFECTIOUS DISEASES, 2017, 64 (03) : 237 - 242
[40] Position statement of the Spanish Society of Paediatric Infectious Diseases on the introduction, implementation and assessment of antimicrobial stewardship programmes in hospital paediatrics
Alfredo Goycochea-Valdivia, Walter
Melendo Perez, Susana
Aguilera-Alonso, David
Escosa-Garcia, Luis
Martinez Campos, Leticia
Baquero-Artigao, Fernando
ANALES DE PEDIATRIA, 2022, 97 (05):

← 1 2 3 4 5 →